Uterine    (DrugBank: -)

2 diseases
IDDisease name (Link within this page)Number of trials
118Myelomeningocele1
288Autoimmune acquired coagulation factor deficiency [Autoimmune Hemorrhaphilia XIII (~Mar 2017)]1

118. Myelomeningocele    [ 9 clinical trials,   15 drugs,   (DrugBank: 7 drugs),   8 drug target genes,   11 drug target pathways]
Searched query = "Myelomeningocele", "Myeloschisis", "Myelocele", "Myelocystocele", "Syringomyelocele"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 9 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04362592
(ClinicalTrials.gov)
November 2, 201824/3/2020In-Utero Endoscopic Correction of Spina BifidaIn-Utero Endoscopic Correction of Spina Bifida: Laparotomy or PercutaneousNeural Tube Defects;Spina Bifida;MyelomeningoceleDevice: In Utero Endoscopic Correction of Myelomeningocele IDE - Percutaneous Technique;Device: In Utero Endoscopic Correction of Myelomeningocele IDE - Laparotomy/Uterine Exteriorization TechniqueUniversity of Southern CaliforniaNULLRecruiting18 Years52 YearsFemale33N/AUnited States

288. Autoimmune acquired coagulation factor deficiency [Autoimmune Hemorrhaphilia XIII (~Mar 2017)]    [ 189 clinical trials,   219 drugs,   (DrugBank: 29 drugs),   18 drug target genes,   26 drug target pathways]
Searched query = "Autoimmune acquired coagulation factor deficiency", "Coagulation factor deficiency", "Factor XIII deficiency", "Factor VIII deficiency", "Acquired hemophilia A", "von Willebrand Disease", "Factor V deficiency"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 189 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03871764
(ClinicalTrials.gov)
December 1, 20158/3/2019Prediction of Outcome in Severe PreeclampsiaRelation of 3rd Trimester Uterine Artery Doppler Flow Velocimetry Indices, Factor V Leiden Mutation and Placental Pathology to the Severity of PreeclampsiaLeiden Factor V Deficiency,Preeclampsia;Doppler Examination;Palental PathologyDiagnostic Test: blood sample , doppler of uterine vessel and placentaCairo UniversityNULLCompletedN/AN/AFemale100NULL